Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Schuchat

Showing results (101-110 of 209) with videos related to

Pageof 21
Sort By:
JAMA|September 22, 1993
Comparison of prevention strategies for neonatal group B streptococcal infection. A population-based economic analysisJ C Mohle-Boetani, A Schuchat, B D Plikaytis, et al.
Emerging Infectious Diseases|April 14, 2004
Severe acute respiratory syndrome, Beijing, 2003Wannian Liang, Zonghan Zhu, Jiyong Guo, et al.
Vaccine|October 14, 2008
Early experience with human papillomavirus vaccine introduction in the United States, Canada and AustraliaAbigail Shefer, Lauri Markowitz, Shelley Deeks, et al.
The Pediatric Infectious Disease Journal|October 11, 2003
Impact of intrapartum antibiotics on the care and evaluation of the neonateSharon Balter, Elizabeth R Zell, Katherine L O'Brien, et al.
Pediatrics|October 3, 2002
Trends in incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and AtlantaTerri B Hyde, Tami M Hilger, Arthur Reingold, et al.
The Journal of Infectious Diseases|September 1, 1990
Population-based risk factors for neonatal group B streptococcal disease: results of a cohort study in metropolitan AtlantaA Schuchat, M Oxtoby, S Cochi, et al.
The Pediatric Infectious Disease Journal|August 1, 1995
Barriers to prevention of perinatal group B streptococcal diseaseH S Jafari, A Schuchat, R Hilsdon, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 10, 2001
Physicians' prevention practices and incidence of neonatal group B streptococcal disease in 2 Canadian regionsH D Davies, C E Adair, A Schuchat, et al.
Vaccine|August 3, 2001
Surveillance for meningococcal disease and strategies for use of conjugate meningococcal vaccines in the United StatesJ R Lingappa, N Rosenstein, E R Zell, et al.
Pediatrics|August 3, 2006
Risk factors for invasive, early-onset Escherichia coli infections in the era of widespread intrapartum antibiotic useStephanie J Schrag, James L Hadler, Kathryn E Arnold, et al.
Pageof 21

Showing results (101-110 of 209) with videos related to

Sort By:
Pageof 21
JAMA|September 22, 1993
Comparison of prevention strategies for neonatal group B streptococcal infection. A population-based economic analysisJ C Mohle-Boetani, A Schuchat, B D Plikaytis, et al.
Emerging Infectious Diseases|April 14, 2004
Severe acute respiratory syndrome, Beijing, 2003Wannian Liang, Zonghan Zhu, Jiyong Guo, et al.
Vaccine|October 14, 2008
Early experience with human papillomavirus vaccine introduction in the United States, Canada and AustraliaAbigail Shefer, Lauri Markowitz, Shelley Deeks, et al.
The Pediatric Infectious Disease Journal|October 11, 2003
Impact of intrapartum antibiotics on the care and evaluation of the neonateSharon Balter, Elizabeth R Zell, Katherine L O'Brien, et al.
Pediatrics|October 3, 2002
Trends in incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and AtlantaTerri B Hyde, Tami M Hilger, Arthur Reingold, et al.
The Journal of Infectious Diseases|September 1, 1990
Population-based risk factors for neonatal group B streptococcal disease: results of a cohort study in metropolitan AtlantaA Schuchat, M Oxtoby, S Cochi, et al.
The Pediatric Infectious Disease Journal|August 1, 1995
Barriers to prevention of perinatal group B streptococcal diseaseH S Jafari, A Schuchat, R Hilsdon, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 10, 2001
Physicians' prevention practices and incidence of neonatal group B streptococcal disease in 2 Canadian regionsH D Davies, C E Adair, A Schuchat, et al.
Vaccine|August 3, 2001
Surveillance for meningococcal disease and strategies for use of conjugate meningococcal vaccines in the United StatesJ R Lingappa, N Rosenstein, E R Zell, et al.
Pediatrics|August 3, 2006
Risk factors for invasive, early-onset Escherichia coli infections in the era of widespread intrapartum antibiotic useStephanie J Schrag, James L Hadler, Kathryn E Arnold, et al.
Pageof 21